| Healthpro Pediatrics | |
|
1818 Harden Blvd Ste 160 Lakeland FL 33803-1824 | |
| (863) 683-4726 | |
| (863) 682-1705 |
| Full Name | Healthpro Pediatrics |
|---|---|
| Speciality | Behavior Analyst |
| Location | 1818 Harden Blvd Ste 160, Lakeland, Florida |
| Authorized Official Name and Position | Kristen Beasley (CLINIC DIRECTOR) |
| Authorized Official Contact | 8134942624 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Healthpro Pediatrics 602 Vonderburg Dr Ste 201 Brandon FL 33511-5900 Ph: () - | Healthpro Pediatrics 1818 Harden Blvd Ste 160 Lakeland FL 33803-1824 Ph: (863) 683-4726 |
| NPI Number | 1598411910 |
|---|---|
| Provider Enumeration Date | 02/24/2022 |
| Last Update Date | 04/03/2024 |
| Certification Date | 04/03/2024 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598411910 | NPI | - | NPPES |
News Archive
Labopharm Inc. today announced it has initiated the regulatory approval process for its twice-daily tramadol-acetaminophen formulation in Europe under the Decentralized Procedure (DCP). The DCP provides an efficient mechanism that allows a company to simultaneously pursue regulatory approval for a medicinal product in multiple jurisdictions in Europe.
A team of researchers have found that the American workplace is a significant contributor to the obesity epidemic. In the review of shifts in the labor force since 1960 it was suggested that a sizable portion of the national weight gain can be explained by declining physical activity during the workday.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
Exelixis, Inc. has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) for XL999, a proprietary novel anticancer compound.
› Verified 4 days ago
Better Minds Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6703 Krenson Oaks Cir, Lakeland, FL 33810 Phone: 786-319-2470 | |
Hull And Associates, P. A. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6700 S Florida Ave, Suite 11, Lakeland, FL 33813 Phone: 863-644-8241 Fax: 863-644-9025 | |
Agape Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6868 N Socrum Loop Rd, Lakeland, FL 33809 Phone: 863-687-6099 Fax: 863-858-1495 | |
Downtown Counseling, P.a. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 S Kentucky Ave, Ste 230, Lakeland, FL 33801 Phone: 863-660-6640 | |
Sanger And Associates - Behavioral And Psychological Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2780 Verandah Vue Way, Lakeland, FL 33812 Phone: 863-944-0841 Fax: 863-583-0480 | |
Whitesands Alcohol & Drug Rehab Lakeland Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5135 Us Highway 98 N, Lakeland, FL 33809 Phone: 863-213-6711 | |
Better Life Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 930 Alicia Rd, Lakeland, FL 33801 Phone: 863-680-1950 Fax: 863-683-4654 |